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Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53 S45knockout (KO) and wild type (WT) mice, or WT mouse chondrocytes
treated with AMPK pharmacologic activator AICAR were subjected to
Western blot analyses for expression of PGC-1a, FOXO3a, SOD2, catalase
and thioredoxin.
Results: NF-kB activation (Ser536 phosphorylation p65 NF-kB), NO
generation and MMP-3 expression induced by IL-1b and TNFa were
enhanced in primary human knee articular chondrocytes with knock-
down of PGC-1a or FOXO3a. In addition, decreased expression of PGC-
1a and FOXO3a, correlated with decreased expression of SOD2, catalase
and thioredoxin, was observed in AMPKa1 KO chondrocytes, compared
with WT chondrocytes. Conversely, activation of AMPK by AICAR
signiﬁcantly increased expression of SOD2, catalase and thioredoxin in
chondrocytes.
Conclusions: Activation of AMPK-PGC-1a and AMPK-FOXO3a pathways
maintain the cellular redox balance in articular chondrocytes by up-
regulating anti-oxidant genes, and inhibit chondrocyte catabolic
responses to inﬂammatory cytokines.
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Purpose: New tools are being developed to extract additional infor-
mation from Genome-Wide Associations studies (GWAS) beyond the
comparisons involving a SNP at a time. A promising area involves
generating a single global statistic for each gene by combining associ-
ation data from each SNP in its locus, hence called Gene-Based Analysis
(GBA). This approach will be particularly useful for genes with multiple
susceptibility polymorphisms of small effect and for genes with several
low frequency susceptibility variants of relative high effect. However,
there are still many standing questions that need to be addressed before
GBA could be widely accepted. We have explored the feasibility of using
GBA for the elucidation of OA genetics.
Methods: We used an approach that accounts for linkage disequilib-
rium between SNPs. This involved the use of statistical tests that take
into account dependence between SNPs deﬁned by the LD structure of
each gene. In addition, we have incorporated information about genetic
recombination for the deﬁnition of each gene. Gene coordinates were
taken from a human genome database (UCSC hg18). This information
was combined with the deCODE recombination maps to deﬁne gene
boundaries [1]. Overlapping genes were combined in a single locus.
About 2.5 million SNPs and their respective p values were taken from
a meta-analysis of 9 OA GWAS [2]. Their positions in the genes were
obtained fromHapMap Phase II+III (rel28) as well as the genotypes used
to obtain the pairwise r squaredmatrix of LD in each locus. This analysis
was done with PLINK. Four different statistics were used to combine p
values from all SNPs in each gene: linear combination test (LCT),
quadratic test (QT), decorrelation test (DT) and Fisher test with an
approximation for dependent p values (FT) [3,4]. All analyses were done
in a cluster of Unix nodes (SVG.CESGA.es).
Results: Combination of the genomic coordinates of 18022 human
genes and the recombination (sex-averaged) map gave 7125 non-
overlapping loci. These loci contained from 1 to 61 geneswith amean of
2.5 genes. Median size of these loci was 170 Kb (IQR 90-300 Kb). First
analyses showed that SNPs with minor allele frequency (MAF) below 5
% disproportionally contributed to the increased complexity of the LD
pattern and to a reduction of the power of statistics accounting for LD.
Therefore, the GBA was performed in two parts: SNPs with MAF over 5
%, with approaches that accounted for LD; and for SNPs withMAF below
5 %, without accounting for LD (not pursued here). For the ﬁrst part, 1.23
million SNPs with p values from the OA GWAS meta-analysis and MAF
larger than 5 % were contained in the genes (median ¼ 117, IQR 60-216).
A pilot study with 100 randomly chosen genes plus two known OA
susceptibility loci (GDF5 and 7q22) showed that two statistics (LCT and
FT) performed reasonably well. They indentiﬁed the two known loci as
the most associated. The other two statistics did not identify any of
them.
Conclusions: There are still obstacles for the use of GBA to extract more
information from OA GWAS data. We have found that two separate
analyses are required because the low frequency SNPs add too muchcomplexity to analyses accounting for the LD structure of the genes. For
SNPs of MAF over 5 %, we have found that all the process including two
of the described statistics perform reasonable well. The other two tests
still do not work adequately. Concordance between the different
statistics is desirable to increase conﬁdence in the results and we
continue working to obtain it by improving deﬁnition of the LD
structure.
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THE OSTEOARTHRITIS SUSCEPTIBILITY GENE GDF5 IS UNDER
EPIGENETIC REGULATION BY DNA METHYLATION - THE
MOLECULAR INTERPLAY BETWEEN GENETICS AND EPIGENETICS IN
DISEASE RISK
L.N. Reynard, C.M. Syddall, J. Loughlin. Newcastle Univ., Newcastle upon
Tyne, United Kingdom
Purpose: GDF5 is involved in chondrogenesis, synovial joint mainte-
nance and repair, and is essential for normal skeletal, bone and joint
development. The rs143383 C to T SNP within the GDF5 50UTR is
associated with OA susceptibility and with susceptibility to other
musculoskeletal phenotypes. rs143383 exerts a joint-wide effect on
GDF5 expression, with expression of the OA-associated T allele being
signiﬁcantly reduced relative to the C allele, a phenomenon termed
differential allelic expression (DAE). We have previously reported that
the GDF5 promoter and 5'UTR are subject to DNAmethylation in human
cell lines and in the soft joint tissues meniscus, fat pad, ligament, and
synovium, and that demethylation of speciﬁc CpG dinucleotides within
the 5'UTR is associated with an increase in the DAE of rs143383. In this
study, we performed a focussed and detailed analysis of the methyla-
tion status of the GDF5 locus in cartilage, the principal tissue affected in
OA and one which we have not examined before. Our aims were to (1)
determine if DNA methylation regulates GDF5 expression in chon-
drocytes, and (2) understand how demethylation of speciﬁc CpG sites in
the 5'UTR affects the DAE of rs143383 and thus OA susceptibility.
Methods: Human articular chondrocytes (HACs) were cultured with
5mM of the demethylating agent 5-aza-2’deoxycytidine (AZA), and gene
expression and DNA methylation assessed by qRT-PCR and bisulphite
sequencing. Macroscopically normal cartilage was obtained from OA
patients who had undergone either total hip (n¼11) or total knee
(n¼13) replacement surgery, with cartilage from fractured neck of
femur (NOF, n¼15) patients used as a non-OA control. Genomic DNA
was extracted, bisulphite converted and methylation of the GDF5 locus
analysed by either pyrosequencing or cloning and Sanger sequencing.
Electrophoretic mobility shift assays (EMSAs) were used to analyse how
methylation of the CpG site at +37 located 3bp upstream of rs143383
affected binding of transacting factors to the C and T alleles of this SNP
and whether this affected GDF5 DAE.
Results: GDF5 transcription was signiﬁcantly increased in HACs
exposed to AZA relative to control cells, with the extent of upregulation
varying between patients from 2.3 to 5.4 fold. There were signiﬁcant
differences in the total methylation of the GDF5 locus in cartilage from
NOF, OA hip and OA knee patients, with the GDF5 CpG island being
signiﬁcantly hypomethylated in OA knee (p<0.0005) and hip (p<0.015)
relative to NOF. The GDF5 5'UTR was also hypomethylated in OA knee
cartilage, with the greatest demethylation observed at the +37 and +106
CpG sites; we have previously demonstrated that AZA-induced deme-
thylation of these sites correlates with increased DAE of rs143383 in-
vitro. A more detailed molecular analysis of how the +37 CpG site
upstream of the rs143383 SNP affects DAE of this SNP was performed
using EMSAs. These demonstrated that methylation of the +37 CpG site
reduced binding of protein complexes to the T allele but not the C allele
of rs143383. This suggests that the AZA induced increase in DAE of
rs143383 we observed previously is the result of increased binding of
a repressor(s) to the T allele of rs143383 caused by the demethylation at
the +37 CpG site.
Conclusions: The methylation status of the +37 CpG site has a signiﬁ-
cant effect on the binding of transcriptional repressors to the T allele of
rs143383, demonstrating that DNA methylation modulates the genetic
effect of the OA-associated SNP rs143383 on GDF5 gene expression. The
inter-individual variability in DAE of rs143383 can therefore be
